Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

From Naked Mole-Rat to Preclinical Pig: Advancing a Regenerative Factor for Myocardial Infarction

Obiettivo

Cardiovascular disease is the leading cause of death worldwide, and myocardial infarction (MI) results in permanent loss of cardiomyocytes, fibrotic scarring, and progression to heart failure. Current therapies primarily limit damage, prevent adverse remodeling, and relieve symptoms, but they do not restore lost myocardium or induce true regeneration, leaving a major unmet clinical need. We have established the naked mole-rat as the first adult mammal capable of true cardiac regeneration, characterized by scar resolution, cardiomyocyte proliferation, and functional recovery. This unique model provides an unprecedented opportunity to discover factors that promote regeneration in the adult heart. Using this approach, we identified a previously uncharacterized, injury-activated extracellular matricellular protein, uniquely present in the naked mole-rat injured zone, which shows pro-regenerative and anti-fibrotic effects in vitro. This PoC proposes to develop this factor as an off-the-shelf regenerative therapy post-MI, delivered via anterograde administration during reperfusion, in alignment with existing clinical practices such as angioplasty. The therapy aims to stimulate cardiomyocyte renewal, limit fibrosis, and orchestrate repair pathways in the adult heart. The factor will be evaluated in a pre-clinical porcine MI model to generate critical data on efficacy in promoting regenerative repair and preventing fibrosis, as well as preliminary systemic safety. These data will provide the necessary evidence to support commercialization and regulatory strategy. To advance translation, the project will secure strong IP protection, early stakeholder engagement, and partnerships with clinical and commercial experts. By offering a context-specific regenerative therapy integrated with current care pathways, this approach has the potential to transform post-MI treatment and prevent heart failure, addressing a critical unmet medical need.

Campo scientifico (EuroSciVoc)

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) ERC-2025-POC

Vedi tutti i progetti finanziati nell’ambito del bando

Istituzione ospitante

KLINIKUM DER UNIVERSITAET ZU KOELN
Contributo netto dell'UE
€ 150 000,00
Indirizzo
Kerpener Strasse 62
50937 Koeln
Germania
Regione
Nordrhein-Westfalen Köln Köln, Kreisfreie Stadt
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
Nessun dato

Beneficiari (1)